ASEAN Economic Community

Supporting you across ASEAN

As the ASEAN Economic Community continues to make great strides towards economic integration, there will be increasing opportunities for multinational companies. The diversity of the political, legal and cultural landscapes within this region are immense and require careful navigation to ensure successful outcomes.

DLA Piper has a long history of advising clients across the key ASEAN countries of Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand and Vietnam. From several of our offices in Asia, most notably Hong Kong and Singapore, we routinely advise on cross-border projects and assignments covering various ASEAN countries.

In those locations where we don't have an office presence, we partner with trusted alliance partners with whom we work on a regular basis to ensure that all legal services are delivered seamlessly with the same high quality, efficiency and proactive approach you would expect from DLA Piper. This means you have one accountable point of contact at all times who will manage your matter efficiently and cost effectively.

Representative Matters

  • Advising CIMB Group, Credit Suisse and JP Morgan on Malaysian Airports' successful equity offering, raising a total of US$298.6 million. The airport operator, which owns the majority of airports in Malaysia, including Kuala Lumpur, intends to use the proceeds to acquire a 40% stake in Istanbul's second-largest international airport, Istanbul Sabiha Gokcen Airport, from India's GMR Group
  • Advising Fosun International on their RMB 210.5 million investment in Secret Recipe Cakes & Cafe (Southeast Asia's largest casual dining chain)
  • Advising a global jewellery chain on the analysis and implementation of a regional headquarters in Asia, including tax, employment and intellectual property considerations across China, Hong Kong, Singapore and Thailand
  • Advising Arvato Systems Singapore Pte. Ltd. on the structured transfer of a business division to HP Systems. Jurisdictions involved were Singapore, Malaysia and Thailand
  • Acting for Wipro Consumer Care and Lighting in respect of its US$144 million multi-jurisdiction acquisition of the L.D. Waxson group involving the acquisition of manufacturing facilities in Malaysia and China and marketing entities in Malaysia, Thailand, China, Hong Kong and Taiwan
  • Advising a private equity firm as sole Asian counsel in connection with a significant GBP investment to the entire Cognita Group, including for Cognita's existing Asian investments. The matter involved Cognita's existing Asian investments utilising investment vehicles in the BVI, Singapore, Thailand and Vietnam and corporate regulatory issues involving Indonesia, Malaysia, Singapore, Thailand, Vietnam, China, Hong Kong and Korea
  • Advising RCG Moody International Limited in relation to the acquisition of ICO Asiapacific group, whose main activity is the inspection of equipment. This complex transaction involved 11 jurisdictions across the Asian region, including Singapore, Brunei, Indonesia, Malaysia, Philippines, Thailand, Vietnam and China
  • Acting for a French listed specialty chemicals company in respect of its US$65 million sale of its distribution and agency business in Asia spanning nine Asia Pacific jurisdictions including Indonesia, Malaysia, Philippines, Thailand, Vietnam, India, Taiwan and Australia
  • Advising Applus Technologies in its 53.3% acquisition of Velosi Limited. The matter involved complicated issues among Velosi Limited's subsidiaries in Brunei, Indonesia, Malaysia and Vietnam
  • Advising Intertek PLC on the acquisition of the assets and business of DNV Veritas group, with specific reference to Indonesia, Singapore and Malaysia
  • Advising an international chemical company on a US$60 million restructuring of its trading businesses in Asia Pacific. The nine jurisdictions involved in the deal were Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, India, Taiwan and Australia
  • Advising on anti-corruption/bribery/undue influence issues relating to a multi-national pharmaceutical company's provision of equipment for epidemiological study /clinical trial in Asia. Jurisdictions included the Philippines, Indonesia, Thailand, India, China, Hong Kong and Taiwan
  • Advising a major pharmaceutical company on obligations regarding the conduct of Board Meetings in the Philippines, Malaysia, Indonesia, Singapore, Thailand, India, Pakistan, China, Hong Kong, Japan, Korea, Taiwan and Australia